Northeast Pharmaceutical Group Co Ltd
SZSE:000597
Northeast Pharmaceutical Group Co Ltd
Operating Expenses
Northeast Pharmaceutical Group Co Ltd
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Northeast Pharmaceutical Group Co Ltd
SZSE:000597
|
Operating Expenses
-¥2.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-9%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Expenses
-¥6.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Expenses
-¥1.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-17%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Expenses
-¥14.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-15%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Expenses
-¥6.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-12%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Operating Expenses
-¥1.1B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Northeast Pharmaceutical Group Co Ltd's Operating Expenses?
Operating Expenses
-2.8B
CNY
Based on the financial report for Dec 31, 2023, Northeast Pharmaceutical Group Co Ltd's Operating Expenses amounts to -2.8B CNY.
What is Northeast Pharmaceutical Group Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-9%
Over the last year, the Operating Expenses growth was 9%. The average annual Operating Expenses growth rates for Northeast Pharmaceutical Group Co Ltd have been -2% over the past three years , 1% over the past five years , and -9% over the past ten years .